OVARIAN CANCER IN WOMEN WITH BRCA1/2 MUTATIONS

Clinical trials for OVARIAN CANCER IN WOMEN WITH BRCA1/2 MUTATIONS explained in plain language.

Never miss a new study

Get alerted when new OVARIAN CANCER IN WOMEN WITH BRCA1/2 MUTATIONS trials appear

Sign up with your email to follow new studies for OVARIAN CANCER IN WOMEN WITH BRCA1/2 MUTATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Aspirin shows promise in blocking ovarian cancer for High-Risk women

Prevention Ongoing

This study tests whether taking aspirin can prevent ovarian cancer in women with BRCA1 or BRCA2 gene mutations, who are at high risk. About 117 participants will take either aspirin or a placebo daily for up to 2 years before their scheduled risk-reducing surgery. Researchers wil…

Matched conditions: OVARIAN CANCER IN WOMEN WITH BRCA1/2 MUTATIONS

Phase: PHASE2 • Sponsor: Canadian Cancer Trials Group • Aim: Prevention

Last updated Jun 15, 2026 19:08 UTC

OVARIAN CANCER IN WOMEN WITH BRCA1/2 MUTATIONS

Get alerted when new OVARIAN CANCER IN WOMEN WITH BRCA1/2 MUTATIONS trials appear

Aspirin shows promise in blocking ovarian cancer for High-Risk women